These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21058408)

  • 1. The discovery and validation of colorectal cancer biomarkers.
    Ang CS; Phung J; Nice EC
    Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted in-gel MRM: a hypothesis driven approach for colorectal cancer biomarker discovery in human feces.
    Ang CS; Nice EC
    J Proteome Res; 2010 Sep; 9(9):4346-55. PubMed ID: 20684568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces.
    Ang CS; Rothacker J; Patsiouras H; Gibbs P; Burgess AW; Nice EC
    Electrophoresis; 2011 Aug; 32(15):1926-38. PubMed ID: 21538981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of biomarkers for colorectal cancer through proteomics-based approaches.
    Tjalsma H
    Expert Rev Proteomics; 2010 Dec; 7(6):879-95. PubMed ID: 21142889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of colorectal cancer: discovering novel biomarkers.
    Skandarajah AR; Moritz RL; Tjandra JJ; Simpson RJ
    Expert Rev Proteomics; 2005 Oct; 2(5):681-92. PubMed ID: 16209648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer.
    Ang CS; Rothacker J; Patsiouras H; Burgess AW; Nice EC
    J Chromatogr A; 2010 May; 1217(19):3330-40. PubMed ID: 19875126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein arrays for biomarker discovery.
    Reid JD; Parker CE; Borchers CH
    Curr Opin Mol Ther; 2007 Jun; 9(3):216-21. PubMed ID: 17608019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer biomarker discovery: Opportunities and pitfalls in analytical methods.
    Issaq HJ; Waybright TJ; Veenstra TD
    Electrophoresis; 2011 Apr; 32(9):967-75. PubMed ID: 21449066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
    Wang K; Huang C; Nice EC
    Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics and biomarkers for ovarian cancer diagnosis.
    Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
    Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis.
    Luo YX; Chen DK; Song SX; Wang L; Wang JP
    Int J Clin Pract; 2011 Dec; 65(12):1313-20. PubMed ID: 22093539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist.
    Søreide K; Nedrebø BS; Knapp JC; Glomsaker TB; Søreide JA; Kørner H
    Surg Oncol; 2009 Mar; 18(1):31-50. PubMed ID: 18672360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.